# Atlas Mobility IC Memo Draft

Recommendation: Hold pending evidence.

Atlas has credible revenue scale and an attractive regional platform thesis, but IC approval should remain conditional until utilization support, customer consent mechanics, and capex sensitivity are resolved.

Top blockers:
- EBITDA normalization depends on utilization improvement.
- Northwind MSA may create a change-of-control consent issue.
- Fleet capex may be understated relative to vehicle age.
- Supplier concentration schedule is not yet analyzed.